The BMP inhibitor follistatin-like 1 (FSTL1) suppresses cervical carcinogenesis
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2023.1100045
Abstract: Follistatin-like 1 (FSTL1) is a cancer-related matricellular secretory protein with contradictory organ-specific roles. Its contribution to the pathogenesis of cervical carcinoma is still not clear. Meanwhile, it is necessary to identify novel candidate genes to… read more here.
Keywords: matched adjacent; like fstl1; fstl1; cervical carcinoma ... See more keywords